Evidence
Swiss Med Wkly. 2024 Jun 3;154:3629. doi: 10.57187/s.3629.
ABSTRACT
BACKGROUND AND AIM: In Switzerland, a cantonal authorisation is required to introduce opioid agonist treatments (OAT). We investigated and compared the terms of these cantonal OAT authorisations throughout Switzerland. The primary objective was to determine how the overseeing cantonal officials implemented and perceived the legal requirements.
METHOD: We started with a cross-sectional analysis of legal texts and cantonal OAT guidelines. Based on the document analysis, we conducted 26 semi-structured interviews with the cantonal officials who grant OAT authorisations.
FINDINGS: In most cantons (21 of 25), the OAT authorisation is specific to the person treated and must be renewed every year. Today, 21 cantons either have implemented or are implementing the same web-based software to process and manage OAT authorisation requests. Cantons have implemented diverging requirements regarding, amongst others, the involvement of third parties in OAT and the training required of prescribing physicians. Lastly, the OAT process does not seem to be a high priority for the overseeing officials.
CONCLUSIONS: From a legal standpoint, OAT authorisations should be straightforward, yet we found significant divergences among cantonal systems. We could not find scientific evidence that supports a given framework. We recommend harmonizing the 26 cantonal systems while reviewing the need for OAT authorisation.
PMID:38885521 | DOI:10.57187/s.3629
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges
- Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
- Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study
- Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study
- What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada
- Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study
- Primary healthcare professionals' attitudes toward patients with current or previous drug use
- What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada
- Clinical reasoning for the continuation or discontinuation of hip precautions after total hip arthroplasty in Switzerland: a qualitative study
- Licensure Policies May Help States Ensure Access To Opioid Use Disorder Medication In Specialty Addiction Treatment
- Prevalence of and risk factors for suicidal ideation in adolescents during the COVID-19 pandemic: a cross-sectional study
- Impact of opioid maintenance therapy in the community on reincarceration in individuals with opioid use disorder-A linked cohort study
- The association of vaccination status with perceived discrimination in patients with COVID-19: results from a cross-sectional study
- A qualitative study of experiences with physical activity among people receiving opioid agonist therapy
- Healthy eating among people on opioid agonist therapy: a qualitative study of patients' experiences and perspectives
- Physician wellbeing and burnout in emergency medicine in Switzerland
- Who was at risk of trauma-related injuries during the COVID-19 pandemic? A retrospective study from a level 1 trauma centre in Switzerland
- Screening for elder mistreatment in a Swiss emergency department: a prospective cohort study
- Cognitive enrichment through art: a randomized controlled trial on the effect of music or visual arts group practice on cognitive and brain development of young children
- Changes in diagnostic patterns and resource utilisation in Swiss adult ICUs during the first two COVID-19 waves: an exploratory study
- Detecting and Validating MAPT Mutations in Neurodegeneration Patients and Analysis of Exon Splicing Consequences
- Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry
- A new approach to cultural scripts of trauma sequelae assessment: The sample case of Switzerland
- Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities
- Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era
- Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype
- Association of Regular Opioid Use With Incident Dementia and Neuroimaging Markers of Brain Health in Chronic Pain Patients: Analysis of UK Biobank
- Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis
- Intimate partner violence after childbirth: an explanatory sequential mixed-methods study protocol
- An Investigation of Patient Preferences and Gender Dynamics of Neurosurgeon selection in Taiwan: A Mixed-Method Study
- Early development of local data dashboards to depict the substance use care cascade for youth involved in the legal system: qualitative findings from end users
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
- Institutional Betrayal in the Criminal and Civil Legal Systems: Exploratory Factor Analysis with a Sample of Black and Hispanic Survivors of Intimate Partner Violence
- Considerations for Opioid Use Disorder Treatment From Policy Makers' Experiences With COVID-19 Policy Flexibilities
- Ethics and law in the application of new technology in forensic psychiatry
- Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term) communities study
- Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies
- Experiences and perspectives of adults on using opioids for pain management in the postoperative period: A scoping review
- "I don't think that a medication is going to help someone long-term stay off opioids": Treatment and recovery beliefs of rural Vermont family members of people with opioid use disorder
- Provision of medications to treat opioid use disorder via a mobile health unit: A scoping review
- Landscape analysis of available European data sources amenable for machine learning and recommendations on usability for rare diseases screening
- "People aren't happy to see refugees coming to Switzerland. They don't like assisted suicide for foreigners": Organizations' perspectives regarding the right-to-die and suicide tourism
- Interdisciplinary research approach based on a mixed-methods design to explore patient altruism at the end of life: a study protocol
- Understanding the integration of artificial intelligence in healthcare organisations and systems through the NASSS framework: a qualitative study in a leading Canadian academic centre
- Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
- That's out! How expert umpires make leg-before-wicket judgements in cricket
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Developing an innovative national ACP-OSCE program in Taiwan: a mixed method study
- Being a child of a parent with a diagnosis of schizophrenia or bipolar disorder: A qualitative study
- Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research
- Comparing attitudes towards compulsory interventions in severe and persistent mental illness among psychiatrists in India and Switzerland
- The influence of familial networks and stigma on prison-based medication initiation for individuals with opioid use disorder: Clinicians' perceptions
- "Being ill was the easy part": exploring cancer survivors' reactions to perceived challenges in engaging with primary healthcare
- Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic
- The magnitude of the plasma hepcidin response to oral iron supplements depends on the iron dosage
- Methadone Withdrawal-Induced Psychosis: A Case Report
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy
- Healthcare and legal systems responses to coercive control: an embodied performance of one woman's experience
- Assessing Student-Reported Perceptions of Prerequisite Usefulness in Preparation for Didactic Physician Assistant Education
- A picture of hope: From the perspective of adolescents with cancer-A phenomenological-visual qualitative study
Evidence Blueprint
Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland
- Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010-2019
- Changes in Opioid Agonist Treatment Practice in Germany during the COVID-19 Pandemic: What Have Physicians Done, and What Would They Like to Keep Doing?
- Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges
- Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada
- The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial
- Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study
- Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
- Caregivers' Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study
- Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study
- Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality
- A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy
- Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
- Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study
- An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study
- Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
- What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada
- Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis
- Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study
- 'It's a fragile open door'-enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder
- The Role of Adverse Childhood Experiences on People in Opiate Agonist Treatment: The Importance of Feeling Unloved
- Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada
- Primary healthcare professionals' attitudes toward patients with current or previous drug use
- Excellent hepatitis C virus cure rates despite increasing complexity of people who use drugs: Integrated-Test-stage Treat study final outcomes
- From Research to Policy: Unveiling Dementia Prevention Efforts in Switzerland
- Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery
- The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews
- Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial
- Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
- What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada
- Clinical reasoning for the continuation or discontinuation of hip precautions after total hip arthroplasty in Switzerland: a qualitative study
- Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
- Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities
- Licensure Policies May Help States Ensure Access To Opioid Use Disorder Medication In Specialty Addiction Treatment
- Age at initial diagnosis of autism spectrum disorders: a retrospective comparison of screening techniques between the southern and northwestern regions of Switzerland
- The effect of nicotine on antidepressant and anxiolytic responses induced by citalopram and citicoline in mice
- Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial
- Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
- Prevalence of and risk factors for suicidal ideation in adolescents during the COVID-19 pandemic: a cross-sectional study
- Synergistic effect between citalopram and muscimol upon induction of anxiolytic- and antidepressant-like effects in male mice: An isobologram analysis
- Impact of opioid maintenance therapy in the community on reincarceration in individuals with opioid use disorder-A linked cohort study
- Launching SwissMedPreprints, the Swiss Medical Weekly's biomedical preprint server
- The association of vaccination status with perceived discrimination in patients with COVID-19: results from a cross-sectional study
- A qualitative study of experiences with physical activity among people receiving opioid agonist therapy
- Healthy eating among people on opioid agonist therapy: a qualitative study of patients' experiences and perspectives
- "They Talk to Me Like a Person" Experiences of People in an Injectable Opioid Agonist Treatment Program: A Qualitative Interpretive Description
- The current and future burden of hepatitis B in Switzerland: a modelling study
- Physician wellbeing and burnout in emergency medicine in Switzerland
- Who was at risk of trauma-related injuries during the COVID-19 pandemic? A retrospective study from a level 1 trauma centre in Switzerland
- Doing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States
- Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience
- A Swiss digital Delphi study on patient-reported outcomes
- Screening for elder mistreatment in a Swiss emergency department: a prospective cohort study
- Cognitive enrichment through art: a randomized controlled trial on the effect of music or visual arts group practice on cognitive and brain development of young children
- Development of a self-report questionnaire for the measurement of stigmatizing attitudes of the psychiatric staff towards patients with borderline personality disorder
- Conflicts between persons with opioid dependency and professionals in an acute hospital: A qualitative document analysis
- Exploring Patients' Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice
- Changes in diagnostic patterns and resource utilisation in Swiss adult ICUs during the first two COVID-19 waves: an exploratory study
- Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone
- Detecting and Validating MAPT Mutations in Neurodegeneration Patients and Analysis of Exon Splicing Consequences
- Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions
- Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry